5,541 to 5,550 of 6,779 Results
Jan 22, 2021 -
NTNU Intranasal Naloxone Trial (NINA-1) Study documents
Plain Text - 3.4 KB -
MD5: 1fd357a16e2d007e86ea902670754e0f
Consult this document for easier access to specific documents |
Jan 22, 2021 -
NTNU Intranasal Naloxone Trial (NINA-1) Study documents
Adobe PDF - 1.9 MB -
MD5: 047a45a69d3a9888429be9fc31d424dd
|
Jan 22, 2021 -
NTNU Intranasal Naloxone Trial (NINA-1) Study documents
Adobe PDF - 2.6 MB -
MD5: ffc0da781af143a83ebb44c6676d2993
This first trial protocol was not approved by Norwegian Medicines Agency. No participants included in the trial under this protocol |
Jan 22, 2021 -
NTNU Intranasal Naloxone Trial (NINA-1) Study documents
Adobe PDF - 3.7 MB -
MD5: da81088a710c80d9917ef3129515966d
This protocol version was valid prior to the inclusion of the first patient. No participants included in the trial under this protocol |
Jan 22, 2021 -
NTNU Intranasal Naloxone Trial (NINA-1) Study documents
Adobe PDF - 3.5 MB -
MD5: 5a87c835c114353cbd447690ea466125
|
Jan 22, 2021 -
NTNU Intranasal Naloxone Trial (NINA-1) Study documents
Adobe PDF - 5.3 MB -
MD5: c32b61b404e56e7794775cfdf10d8bd4
|
Jan 22, 2021 -
NTNU Intranasal Naloxone Trial (NINA-1) Study documents
Adobe PDF - 1.7 MB -
MD5: b50af244dc9512517fc6573fc002f4f5
|
Jan 22, 2021 -
NTNU Intranasal Naloxone Trial (NINA-1) Study documents
Adobe PDF - 2.9 MB -
MD5: fadb8e879384d400b763ccb91a4e3b04
Example informed consent information forms from study kit and online version |
Jan 22, 2021 -
NTNU Intranasal Naloxone Trial (NINA-1) Study documents
Adobe PDF - 1.1 MB -
MD5: 22f771682f3dc9ea8e914a86bd00dd01
Annual Safety reports submitted to Norwegian Medicines Agency |
Jan 22, 2021 -
NTNU Intranasal Naloxone Trial (NINA-1) Study documents
Adobe PDF - 341.8 KB -
MD5: 6b5a9190b6ecd5a3da166b583b2a11ff
|